Food-derived bioactive peptides (BPs) have gained popularity due to their potential health benefits against diseases such as hypertension, type 2 diabetes, inflammatory diseases, neurodegenerative diseases, and obesity. However, the efficacy of BPs depends on their bioaccessibility and bioavailability, which are influenced by many factors such as physicochemical properties, protease enzymes in the gastrointestinal (GI) tract, food matrix interactions, processing methods, and intestinal barrier interaction. Thus, encapsulation is a potential approach for the protection, controlled release, and delivery of BPs thereby enhancing the bioaccessibility and bioavailability. Numerous studies have investigated the intestinal transport and bioavailability of BPs. However, there remains a gap in understanding their effects through ex vivo or in vivo experiments. Moreover, the results of in vitro studies are not entirely translatable to other in vivo models due to systemic physiological differences. Therefore, this chapter sheds light on the transport mechanisms of BPs, methods for assessing the bioaccessibility and bioavailability of BPs, factors influencing the bioaccessibility and bioavailability of BPs, and strategies for enhancing the bioavailability of peptide delivery systems. The chapter also discusses challenges and potential avenues for improving the bioaccessibility and bioavailability of BPs.